Etoricoxib (arcoxia) in rheumatology

The paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatology

Bibliographic Details
Main Authors: Fatima Magomedovna Kudaeva, V G Barskova, Fatima Magomedovna Kudayeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2011-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/356